VivoSim Labs, Inc.

VIVS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2012 FY2011 FY2010
Revenue $4.6M $4.2M $1.5M $571.0K $379.0K $1.2M $969.0K $603.0K
Cost of Revenue $1.0M $956.0K $0 $0 $121.0K
Gross Profit $3.6M $3.3M $1.5M $571.0K $848.0K
Gross Margin 78.3% 77.4% 100.0% 100.0% 87.5%
Operating Expenses
Research & Development $18.0M $19.5M $18.0M $12.9M $8.0M $3.4M $1.4M $1.2M
SG&A Expense $20.9M $22.3M $22.1M $17.9M $13.1M $7.1M $1.7M $578.0K
Operating Income $-35.3M $-38.6M $-38.6M $-30.3M $-20.6M $-9.3M $-2.3M $-1.2M
Operating Margin -766.3% -911.9% -2,605.7% -5,306.0% -5,448.3% -778.5% -237.9% -195.4%
Interest Expense $0 $0 $1.0K $13.0K $1.1M $2.1M $161.0K
Pretax Income
Income Tax Expense $2.0K $23.0K $3.0K $0 $0
Net Income $-34.8M $-38.4M $-38.6M $-30.1M $-25.8M $-43.6M $-4.4M $-1.3M
Net Margin -756.1% -908.9% -2,601.1% -5,268.3% -6,820.1% -3,638.5% -452.3% -222.1%
EPS (Basic) $-0.32 $-0.39 $-0.43 $-0.38 $-0.35 $-1.01 $-0.19 $-0.09
EPS (Diluted) $-0.32 $-0.39 $-0.43 $-0.38 $-0.35 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 111.1M 104.6M 92.4M 81.6M 78.3M 58.5M 22.4M
Shares Outstanding (Diluted) 111.1M 104.6M 92.4M 81.6M 78.3M 58.5M 22.4M
Dividends Per Share
← Newer Page 2 of 2 Older →